Unlabelled: Prostate cancer (PCa), the most common solid malignant neoplasm in men, is characterized using the Gleason score and diagnosed using prostate-specific antigen (PSA) biomarker. However, Gleason score and PSA-based diagnostics are not universal and have significant limitations. It is supposed that the ornithine decarboxylase activity (A) could be a suitable auxiliary biomarker for the PCa diagnosis or monitoring the therapeutic efficacy.

Aim: To assess the relation between A in PCa tissues and the level of serum PSA with the Gleason score (GS) and the clinical stage.

Materials And Methods: 29 patients (48 to 79 years old) with prostate adenocarcinoma of different GS (6 to 10) and clinical stage (T1 to T4) were enrolled in the study. The A was analyzed in the PCa tissues by the modified spectrophotometric assay.

Results: The patients with PCa were distributed into two groups: with low A < 0.3 and high A > 0.45. In group with A < 0.3, the highest value of A was recorded in patients with the lowest GS (= 6), while in group with A > 0.45, the highest value of A was recorded in the patients with the highest GS (= 9-10). Furthermore, in group with A > 0.45, the highest value of A was registered in the patients with T1 or T4 stage. The highest levels of serum PSA were detected in T3-T4 cases and in cases with the highest GS.

Conclusion: The patterns of A and serum PSA can be used as supplementary indices useful for monitoring PCa course.

Download full-text PDF

Source
http://dx.doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-1.16011DOI Listing

Publication Analysis

Top Keywords

gleason score
12
serum psa
12
a > 045
12
ornithine decarboxylase
8
decarboxylase activity
8
prostate cancer
8
pca tissues
8
highest recorded
8
recorded patients
8
group a >
8

Similar Publications

Objectives: To study the predictive role of tumor-associated neutrophils in early luminal HER2-negative breast cancer.

Materials And Methods: This is a retrospective study conducted on 60 women cases aged from 31 to 79 years underwent surgery for luminal HER2-negative ductal breast cancer in tertiary care cancer centre. We first estimated basic morphological signs: tumor size, tumor grade (by Nottingham Histologic Score), tumor infiltrating lymphocytes (TILs), Lymphovascular invasion, hormonal receptors status, proliferative index, and regional lymph nodes metastasis.

View Article and Find Full Text PDF

Objective: To determine the correlation among five different types of tumor regression grading (TRG) systems. Test-retest reliability analyses were conducted at two time points to assess the internal validity and consistency of these five TRG systems.

Methods: A test-retest study was performed in 34 pathologically confirmed rectal adenocarcinoma specimens.

View Article and Find Full Text PDF

Objective: This study aimed to investigate the influence of p16 immunohistochemical expression on the biochemical recurrence rate of pT2-pT3 prostate cancer.

Materials And Methods: A total of 488 pT2-pT3 stage prostate adenocarcinomas undergoing radical prostatectomy were included in this study. Following a review of Gleason classification and retrieval of sociodemographic and clinicopathological data, as well as the date of last consultation and biochemical recurrence, immunohistochemistry for p16 was performed.

View Article and Find Full Text PDF

Prognostic factors for overall survival in castration-resistant metastatic prostate cancer treated with docetaxel (MeProCSS): results from a German real-world cohort.

Int Urol Nephrol

January 2025

Department of Urology and Urosurgery, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Baden-Württemberg, Germany.

Purpose: To identify prognostic factors for overall survival (OS) and develop a prognostic score in patients receiving docetaxel in metastatic castration-resistant prostate cancer (mCRPC).

Methods: Retrospective analysis was conducted on mCRPC patients treated with docetaxel at a German tertiary center between March 2010 and November 2023. Prognostic clinical and laboratory factors were analyzed using uni- and multivariable logistic regression.

View Article and Find Full Text PDF

Purpose: Conventional prostate magnetic resonance imaging has limited accuracy for clinically significant prostate cancer (csPCa). We performed diffusion basis spectrum imaging (DBSI) prior to biopsy and applied artificial intelligence models to these DBSI metrics to predict csPCa.

Materials And Methods: Between February 2020 and March 2024, 241 patients underwent prostate MRI that included conventional and DBSI-specific sequences prior to prostate biopsy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!